A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis - Wikidata - wikimedia - TriplyDB

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

http://www.wikidata.org/entity/Q28256067

about

Expression profile of the entire family of Adhesion G protein-coupled receptors in mouse and rat METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity Isolation and characterization of a novel TP53-inducible gene, TP53TG5, which suppresses growth and shows cell cycle-dependent transition of expression The transcription factor p53: not a repressor, solely an activator A family of heptahelical receptors with adhesion-like domains: a marriage between two super families Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro Brain-specific angiogenesis inhibitor-1 signaling, regulation, and enrichment in the postsynaptic density The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins Identification of semaphorin3B as a direct target of p53 A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative bacteria.Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis Cyclin K as a direct transcriptional target of the p53 tumor suppressor Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression Octylphenol and UV-B radiation alter larval development and hypothalamic gene expression in the leopard frog (Rana pipiens)Emerging Roles of BAI Adhesion-GPCRs in Synapse Development and Plasticity The BAI subfamily of adhesion GPCRs: synaptic regulation and beyond Anti-angiogenic gene therapy in the treatment of malignant gliomas Crystal structure of the TSP-1 type 1 repeats Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53 GPR126 protein regulates developmental and pathological angiogenesis through modulation of VEGFR2 receptor signaling International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors Targeted deletion of the epididymal receptor HE6 results in fluid dysregulation and male infertility Activation and activities of the p53 tumour suppressor protein A novel ubiquitously expressed alpha-latrotoxin receptor is a member of the CIRL family of G-protein-coupled receptors The adhesion-GPCR BAI1 regulates synaptogenesis by controlling the recruitment of the Par3/Tiam1 polarity complex to synaptic sites.Molecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36 Adhesion GPCRs as Modulators of Immune Cell Function.Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis.The Dynamics of Apoptotic Cell Clearance Apoptotic cell recognition receptors and scavenger receptors.Case report: Increased viral receptor expression associated with high viral load and severe pneumonia in a young patient infected with 2009 H1N1 influenza a with no pre-existing conditions.Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS BAI1 regulates spatial learning and synaptic plasticity in the hippocampus Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1.Adhesion GPCRs in Tumorigenesis.Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.

P2860

Q21093337-95931D7D-9C47-4743-A79E-FC14FE8AEC18 Q22010478-FD13FC0D-E565-492C-A0AF-C6AEF27CEC91 Q22253342-BAE90108-7FB0-42B0-A610-EED0E6BD09E7 Q24273295-2684B8D7-33D5-4D63-8E2E-645BCA3D1765 Q24290272-2F11CBD7-9394-450C-826D-08CEAEC8F0B8 Q24291158-BAED933C-F680-473C-ADB3-835D04EC5C9B Q24295603-107835FB-65B9-4548-A13F-D3C0B796D46F Q24338193-87BB92B4-071A-4E27-86C3-7D2A865032DE Q24550987-79EB0487-D15E-4932-BD1A-BE5177FEFD8F Q24602445-72679C5E-B8F7-4B82-A146-98F30C587D49 Q24630946-7DFA9FAF-7654-4C98-A430-A18C958BE663 Q24642994-A07EE871-47F9-4084-9C60-E59BC81207A3 Q24682907-3229486E-4D70-48DC-858D-9CFB18D8E119 Q24684369-5A003C00-04E1-473F-B430-A7655F3D4030 Q24815949-2B2767F2-CCC7-4582-A1A9-67B99CF45479 Q26765596-845A393D-7F44-4C4A-A013-C94CECE9A8EA Q26864858-8CB6554A-F359-459D-8206-12743C7AF270 Q26866276-7AEA63CE-4D55-44C2-B52C-C8A9640F0CE2 Q27639866-0932747B-B669-4F34-A0A2-92025F65C411 Q28141127-200CFE8C-1BBA-4635-9270-CEDAA9E32563 Q28198140-5D107255-0766-43DC-9CA7-5B103CD4328B Q28204132-47DF7DEB-CC4B-4B80-BE47-242CEDCA66EF Q28247820-4AE04FB5-E4CB-4464-BC94-AE96AC283AFE Q28257710-427DED4C-E603-4A6F-ABC5-42CA3C928055 Q28282128-56BA289C-A408-4713-8E07-6AB23F711480 Q28366563-ED992B6D-C6E3-4919-92A9-20A8BE7BACC1 Q28369891-8239BB68-D9D5-49EA-ADC8-F6C0D38C47EA Q28571945-832F456C-5437-4B88-BC05-0B09704B169D Q29147397-58AFD39D-02D5-4B94-A258-9C625F248117 Q30275444-FB614D39-63C9-4DB3-9341-DD60BC4E8B01 Q30276066-63209F75-F8A6-4698-964D-A108266AEAA4 Q30276273-67A4BBE2-4445-4672-BCA7-BE8AA4446F35 Q30277892-BB4A70B9-D4D0-4DBD-981A-0B3EAC44CC6B Q30411777-2AB9BDB0-E100-47DE-B820-40F3EF5ED3B8 Q31110558-ED7BBAF9-AD83-43A1-BF68-646A923EB948 Q33112266-720845BE-2C06-48DD-BE49-81B110C18AA1 Q33112684-E6A76591-C5A2-4CBD-8A70-998EC1C570C5 Q33112696-B95F6319-8529-408C-B86D-C1862055D1C5 Q33558191-82594E89-77C2-41EE-9502-E9831319251E Q33638847-E405D303-4552-4C6F-99E7-55CC8060D291

P2860

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

http://www.wikidata.org/entity/Q28256067

description

1997 nî lūn-bûn

@nan

1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@ast

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@en

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@nl

type

label

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@ast

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@en

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@nl

prefLabel

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@ast

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@en

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@nl

P1433

Q28256067-26BCA4E8-A742-428A-91F9-5100F38D45CA

P1476

Q28256067-3057DFFB-ADA9-48B6-B99D-A88EF9EA03F1

P2093

Q28256067-047DD796-6E02-4DE5-8C0D-E90196D80A71

Q28256067-927D6DDA-3DC2-4564-BA5A-9F9308DD7561

Q28256067-A2346706-D14F-4B64-8560-E043D52DA42D

Q28256067-A4D5ACD0-7285-4F2D-8F02-236473A2481D

Q28256067-BA3F01BE-7E0D-43DD-A491-054899C482C9

Q28256067-BF15233F-45B1-490F-887D-7E8AD822DD88

Q28256067-C7D580AB-C03A-4FA3-9831-D006D9E34DCB

Q28256067-C7EA14BE-37B6-432C-B568-EDB83CB9B1E0

Q28256067-CA7AF2B9-1FC2-492E-BF21-B5E808F35C00

Q28256067-CC24C0C7-1056-4EFA-8FAD-659D76C2FD38

P2888

Q28256067-F3422610-0B67-4719-8613-C47F43C71CFA

P304

Q28256067-12F9AB52-9FD7-4605-B6B7-83DA6F324804

P31

Q28256067-B0F6F1C0-2906-4211-B069-DC13077477C6

P3181

Q28256067-5A9264A3-28FB-4829-A5F5-DAD0DE0EEF43

P356

Q28256067-B1F8E1D2-D9AE-4567-98B6-B845F272972E

P407

Q28256067-69AC71AA-4872-4E88-8904-ED486AEF8D67

P433

Q28256067-3A82ADA9-AB9B-4894-8EDB-5C335CDED0E8

P478

Q28256067-F79B3873-A8A3-424D-851C-262B87A3ECDB

P577

Q28256067-1F73FC0B-2F17-4A50-BEB6-02CC8BDF5592

P5875

Q28256067-F1719F96-36EE-4E2A-AAE2-312E27E753D9

P6179

Q28256067-30C09DBC-85D6-4C28-941B-B8C470BFED60

P698

Q28256067-905C77AB-A36F-4FDC-A460-97EDEEFF1D7E

P921

Q28256067-79FA3F92-B430-4013-B3D3-2B8EB7649A30

P3181

P356

P1433

P1476

A novel brain-specific p53-tar ...... bits experimental angiogenesis

@en

P2093

H Nishimori

http://www.w3.org/2001/XMLSchema#string

K Kiyono

http://www.w3.org/2001/XMLSchema#string

K Tatsumi

http://www.w3.org/2001/XMLSchema#string

M Kuwano

http://www.w3.org/2001/XMLSchema#string

M Ono

http://www.w3.org/2001/XMLSchema#string

S Yoshida

http://www.w3.org/2001/XMLSchema#string

T Shiratsuchi

http://www.w3.org/2001/XMLSchema#string

T Tokino

http://www.w3.org/2001/XMLSchema#string

T Urano

http://www.w3.org/2001/XMLSchema#string

Y Kimura

http://www.w3.org/2001/XMLSchema#string

P2888

P304

2145-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

561327

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.ONC.1201542

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

1997-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13836112

http://www.w3.org/2001/XMLSchema#string

P6179

1016466327

http://www.w3.org/2001/XMLSchema#string

P698

9393972

http://www.w3.org/2001/XMLSchema#string

P921